Abstract-Irreversible electroporation (IRE) can be used to treat cancer by electrical pulses, with advantages over traditional thermal approaches. Here we assess for the first time the IRE response of pancreatic cancer, one of the deadliest forms of cancer, both in vitro and in vivo. We demonstrate that both established and primary cancer cell lines can be destroyed by IRE, but with differential susceptibility and thresholds. We further demonstrate in vitro that viability for a given IRE dose can vary with the local chemistry as outcomes were shown to depend on suspending medium and reduction of glucose in the media significantly improved IRE destruction. Data here also demonstrate that repeated IRE treatments can lead to adaptive resistance in pancreatic carcinoma cells thereby reducing subsequent treatment efficacy. In addition, we demonstrate that physical enhancement of IRE, by re-arranging the pulse sequences without increasing the electrical energy delivered, achieve reduced viability in vitro and decreased tumor growth in an in vivo xenograft model. Together, these results show that IRE can destroy pancreatic cancer in vitro and in vivo, that there are both chemical and physical enhancements that can improve tumor destruction, and that one should guard against adaptive resistance when performing repeated treatments.
INTRODUCTION
As pancreatic cancer remains one of the deadliest forms of cancer, there is an ongoing search for new and improved treatments. 19 While surgical resection remains the most likely curative option for pancreatic ductal adenocarcinoma (PDA), only~80% of PDA patients present with surgically unresectable disease, resulting in a lower 5-year survival compared to patients that undergo resection. 26, 42 Approaches to treat established primary or metastatic disease, and perhaps increase the potential for resection, include the use of focal therapies, including endoscopic delivery of chemotherapy, cryotherapy, photodynamic therapy, and radiofrequency (RF) ablation. However, these approaches need to either provide a unique treatment or be at least comparable to standard treatments. 48 However, many of these approaches are currently limited. For instance, implementation of heat approaches (i.e., RF) can be limited by concerns about thermal injury to adjacent organs and vessels leading to bleeding 47 or bile duct fistulae or leakage. 33 In addition, the success of thermal diffusion based approaches (i.e., cryotherapy and heat) can be impacted by local perfusion (i.e., blood flow source or sink). 6 In short, the use of focal thermal therapies in pancreatic cancer has largely been avoided due to the possibility of under treatment due to perfusion effects in adjacent vessels, 37 or the possibility of over-treatment which can induce pancreatitis. ond electrical pulses which, when properly designed, can permeabilize and locally destroy cancer cells. Further, IRE can be used to non-thermally destroy large volumes of tissue in a controlled manner with several groups reporting sharp boundaries between affected and unaffected tissues. 8, 9 Finally, IRE leads to cell death but does not injure the extracellular matrix or compromising the structural integrity of large vessels; thus preserving structural components and potentially avoiding complications of traditional thermal therapy. 9, 31 For these reasons, IRE is being investigated as a focal therapy for locally advanced pancreatic cancer. 24 The outcome of IRE on pancreatic cancer will depend on IRE parameters as well as cancer biological characteristics (e.g., susceptibility, size, shape and degree of local invasion) and local chemistry (i.e., chemical environment the cells are directly exposed to). For instance, the IRE parameters including pulse amplitude, duration, and the number of pulses needed to destroy pancreatic cancer cells
are not yet known. 3 Further, it has been estimated that ideally the cancer tumor size should be £3.0 cm, and that the procedure can take up to 60 min because of the need for multiple probe pairing and placement sessions. 32 Thus, there remain important questions about IRE dosing in pancreatic cancer including: (1) baseline in vitro and in vivo thresholds of IRE in pancreatic cancer, (2) conditions for physical enhancement (i.e., pulse design), (3) chemical enhancement (i.e., local chemistry and/or glucose deprivation), and (4) the impact of repeated treatments (i.e., adaptation).
In this paper, we report on pancreatic cancer response to IRE for the first time. Two different types of pancreatic cancer cells (AsPC-1 and KPC) are treated with IRE over a range of clinically relevant electric fields and pulse parameters in vitro. AsPC-1 is taken forward for extensive enhancement tests. Specifically, we investigate and evaluate physical approaches for IRE enhancement. We change the electrical parameters (pulse timing and frequency) while keeping the total energy constant to achieve both in vitro and in vivo enhancements. Further, we demonstrate that the chemical environment (i.e., culture media and glucose concentration) can influence IRE outcomes. Finally, we demonstrate the first evidence of pancreatic cancer cells developing adaptive resistance to IRE, in which cells are less susceptible to a new IRE treatment after a previous IRE treatment. Together, these results begin to frame the appropriate physical and chemical conditions of IRE use for treatment of pancreatic cancer.
MATERIALS AND METHODS

Cell Culture
Validated human (AsPC-1) pancreatic adenocarcinoma cells were obtained from ATCC. Primary KPC cells were isolated from a pancreatic adenocarcinoma in the genetically engineered Kras G12D/+ ; Tp53 R172H/+ ; Pdx1-Cre (KPC) murine model of human cancer [approved by the Institutional Animal Care and Use Committee (IACUC), University of Minnesota] and previously described. 40 This model is faithful for the genetic, histologic, and clinical evolution of PDA. 17, 40 AsPC-1 cells were cultured in a medium consisting of Roswell Park Memorial Institute (RPMI) medium 1640, 2 mM glutamine, 1 mM sodium pyruvate, 10% fetal bovine serum (FBS), 100 U/mL Penicillin and 100 lg/mL streptomycin. KPC cells were cultured in Dulbecco's modified eagle medium (DMEM) with 4.5 g/L glucose, 10% FBS, 100 U/mL penicillin and 100 lg/mL streptomycin. Human dermal fibroblasts (HDFs) were cultured as previously described. 30 All cells are cultured in T flasks incubated at 37°C with 5% CO 2 . Once reaching 70-85% confluency the flasks were exposed to trypsin-EDTA (0.05% and 0.53 mM) for 5 min and split 1:3-1:6 to continue culture, or (at 85% confluency) used immediately for experiments.
In Vitro Assessment and Enhancements
After culture and harvest as above, the total number of cells from each flask were counted by a hemocytometer. Cell pellets were made from suspensions centrifuged at 2009g for 5 min and the supernatant was removed. Cells were re-suspended in their original cell culture medium as described above to final cell density of 0.2-0.6 9 10 6 cells/mL, unless otherwise stated. While in suspension, the cell sizes were measured by an automated cell counter (Countess II, Invitrogen). The brightfield microscopic images of the cells were captured, processed and analyzed by the built-in software (v1.0.247).
The in vitro experimental set-up is shown in Fig. 1a . For each IRE test, 400 lL of the prepared cell suspension was pipetted into an electroporation cuvette (FB102, Fisher Scientific) between the two plate electrodes (2 mm apart). The cuvette was then placed in an external electric field created by an electric pulse generator (BTX ECM 830, Harvard apparatus). The electrical parameters, shown in Fig. 1b , were set from the pulse generator, with electric field determined by voltage applied/distance between electrodes. The electrical pulse duration and pulse interval were set to 50 ls and 100 ms (i.e., pulse frequency of 10 Hz), unless otherwise stated.
Post-IRE cell viability was evaluated using a tetrazolium-based cell counting kit-8 (CCK-8) assay (Dojindo Molecular Technologies), which has been widely used in assessing viability of a variety of pancreatic cancer cells. 2, 39 While numerous viability assays exist with various strengths and weaknesses, 38 we have elected to use CCK-8 as a simple and effective approach to assess metabolic activity after IRE treatment. Following IRE, 100 lL aliquots of the electroporated cell suspensions were mixed with 10 lL of CCK-8 reagent in a flat-bottomed 96-well plate and incubated for 4 h at 37°C in the incubator with 5% CO 2 . The optical absorption of the sample was then read in a spectrophotometer (Synergy, BioTek) at a wavelength of 450 nm. The viabilities of a specific sample were determined by normalizing the absorption to a calibration curve, which is made of untreated cells in suspension from the same culture condition (control = 100% viability), the same solution containing no cell (0% viability) and half of the amount untreated cells (50% viability). The viability is shown as average ± standard deviation from n ‡ 6 replicates. Single For comparing medium effect, cells were suspended in phosphate buffered saline (PBS), DMEM or RPMI to the same density. For comparison, the effect of glucose level, cells were suspended to the same medium except for different glucose concentration. IRE treatments were performed immediately after the cells were exposed to new medium. (e) Experimental design for adaptive resistance. Cells were derived from the same flask. Following resuspension and distribution into cuvettes, cells in both groups (control vs. IRE treatment) were replated and cultured for 5 days under the same conditions. Lastly, the cells in each group were tested for viability after IRE under a same set of parameters.
factor ANOVA tests were performed on experimental groups where p value was taken to delineate statistical significance among groups. p value less than 0.05 is considered to be statistically significant.
Physical Enhancement
In vitro IRE physical enhancement was accomplished by arranging the electrical pulses while keeping the total number of pulses and waveform of individual pulse (i.e., total energy) unchanged. The effect of physical enhancements was tested on AsPC-1 cell suspensions to assess the viability after different IRE treatments, as shown in Fig. 1c . Here, the baseline of IRE parameters (51 pulses, 50 ls duration) was chosen to keep consistent with previous published ones. 20, 21 The electric field was set between 1250 and 1750 V/cm to achieve 50-75% cell death after IRE to leave room for more cell death after enhancement.
Chemical Enhancements
Chemical enhancement was investigated by comparing the effects of IRE on AsPC-1 pancreatic cells suspended in different solutions and through glucose deprivation, as shown in Fig. 1d . AsPC-1 cells were cultured, grown and harvested as above and equally divided into different treatment groups. Cell suspensions were centrifuged and then resuspended in different media (original basal medium recipe without additives) to final cell density of 0.4 9 10 6 cells/mL. 99 IRE pulses were applied to different cells suspension with electric field of 750, 1000, and 1250 V/cm. Another chemical enhancement with different glucose concentration in the media was prepared with final glucose concentration ranging from 80 to 380 mg/dL. After harvest, the same batch of AsPC-1 cells were rinsed with phosphate-buffered saline (PBS) twice and re-suspended at the same density in a series of solutions. This set of solutions is made up of the original recipe of cell culture medium (described previously) and only differs in the concentration of glucose. All cell suspensions were exposed to the same IRE parameters (1750 V/cm, 50 ls pulse duration, 1 Hz and 51 pulses). Four sets of experiments were conducted and results are reported as the average viability ± standard deviation.
Adaptive Resistance
We designed a test for adaptive resistance post IRE as shown in Fig. 1e . Here AsPC-1 cells were cultured normally with the media changed the day before harvest. On the day of testing the cells were detached, rinsed and re-suspended in PBS at a density of 1 9 10 6 cells/mL which was used for control and treatment groups. In the first control group, 1/5 of the prepared cell suspension was transferred to sterile electroporation cuvettes without applying an electric field. In the second treatment group, 4/5 of the cell suspension was transferred to cuvettes where they were exposed to IRE (1000 V/cm, 50 pulses, 50 ls duration and 1 Hz). These parameters have shown roughly 25% survival previously. The cells from both groups were then transferred to new flasks filled with fresh cell culture medium. In both groups, culture media was further changed day 1 and 3 after the treatment, which also removed dead (unattached) cells from the flasks. At day 5, the cells from flasks of both control and treatment groups were harvested, suspended at a density of 0.4 9 10 6 cells/mL in PBS and tested for viability after IRE with the same initial parameters (1000 V/cm, 50 pulses, 50 ls duration and 1 Hz). The simple composition of PBS eliminates interference of other organic and inorganic compounds during the electroporation process.
In Vivo Assessment and Enhancement
All animal usage and experimental procedure protocols were reviewed and approved by IACUC. Male nude mice (6-8 weeks, athymic nude-Foxn1 nu , Harlan Laboratories) were injected with 1 9 10 6 AsPC-1 cells in 100 lL suspension (50% Matrigel and 50% PBS) subcutaneously over the dorsal flanks near the hind limbs under a brief anesthesia by inhaling 5% isoflurane.
An IRE probe was constructed and used in vivo based on a previous probe design. 21 The geometry of the probe is shown (Fig. 2a) . The IRE electric field distributions in the hindlimb tumor were modeled using COMSOL Multiphysics (Version 4.4). The modeling was done on a plane at the center of the tumor and perpendicular to the electrodes, using the actual geometry of a typical tumor and the IRE probe. Simulations were conducted with settings and parameters described in Ref. 21 .
The probe was comprised of two needle-type electrodes, each with a conductive tip (i.e., exposed without insulation). The needle electrodes were made from 304 fully hardened stainless steel and the tips of the needle electrodes are made of 1 mm trocar ground down for easier penetration through the skin and into a tumor. The base was machined from white Acetal/ Delrin with a 10-24 UNC pinch screw for precise needle fixation. 24 AWG stranded electrical wires were terminated to the proximal ends of the needle electrodes and to the banana connectors.
Experiments were performed 12-24 days after tumor seeding when spherically shaped tumors had reached total volume of roughly 100 mm 3 (major axis 8-10 mm, minor axis 6-8 mm), as shown in Fig. 2a .
Mice with irregular shaped tumors were not included in the experiments. The resulting 47 mice were randomized into the four groups for experiments. Animals were placed under general anesthesia (by ketamine and xylazine) before the procedure. Directly prior to each IRE probe insertion, the applicator was wiped with ethanol pads to avoid any infection. The needle electrodes were then inserted symmetrically to the center of the hindlimb tumor through the skin. Sham procedure was performed on 17 mice that received no other treatment than needle penetration (i.e., no IRE).
Physical Enhancement
Baseline parameters were selected to destroy part of the tumor (based on the electric field distribution simulation), to allow comparison to enhanced treatments in enhancement groups. Besides a group of sham procedures, all three treatment groups all receive 51 IRE pulses (600 V between two electrodes, 50 ls pulse duration), except the pulses were arranged differently as shown in Fig. 2c . The overall treatment time was less than 2 min in all cases. After IRE treatment, the mice were returned to their cages, allowed to recover and monitored for 40 days after the IRE treatment.
Tumor growth measurements were taken every 5 days using a caliper. The length of the major axis (L), minor axis (S), were measured three times and the averaged values were recorded and used to calculate tumor volumes (V) by an established modified ellipsoidal formula V = 0.5 9 L 9 S^2.
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RESULTS
In Vitro Assessment and Enhancement
The responses of primary KPC (murine) and AsPC-1 (human) PDA cells to IRE are shown in Fig. 3 . Results show that both KPC and AsPC-1 can be destroyed by IRE and that increased pulse number and higher electric field led to lower viability after IRE. However, the KPC are more susceptible to IRE than AsPC-1 under the same conditions of testing. For example, when comparing 50 pulses at 750 V/cm, IRE resulted in 14.24% viability drop in KPC vs. 2.60% in AsPC-1 (p < 0.05). Further, at 1000 V/cm and KPC drop was 52.81 vs. 30.12% in AsPC-1 (p < 0.05). Finally, with 10 pulses, substantially less KPC cells survived compared to AsPC-1. For instance, 85.39 vs. 97.34% at 750 V/cm, and 64.05 vs. 90.39% at 1000 V/ 
Physical Enhancement
Physical enhancements of IRE on AsPC-1 were taken forward into physical and chemical enhancement studies. Here, physical enhancement was investigated by keeping the total energy delivered the same (51 pulses, 50 ls/pulse) but using different pulse timing and frequency of pulsing at a given electric field. Specifically, pulse timing, defined as the total pulses spread out by a delay between trains, and decreased frequency from 10 to 1 Hz were evaluated as potential enhancements at a given electric field over baseline parameters (51 pulses, 50 ls/pulse, 10 Hz). Indeed, pulse timing and reduced frequency can enhance cell destruction by IRE at a given electric field (Fig. 4a) . Pulse timing led to a roughly 5-10% drop in viability over baseline at each electric field tested. Moreover, the 1-Hz pulsing arrangement led to a 15-25% drop in all tested electric fields.
Chemical Enhancements
Switching the media of cells in suspension prior to electroporation was shown to enhance IRE cell destruction (Fig. 4b) . At 750 V/cm, the cell viability in PBS, DMEM and RPMI medium were 50, 74, and 97%, respectively (p < 0.01). This trend continued at higher electric fields including 1000 V/cm (18, 22 , and 86%) and 1250 V/cm (10, 10, and 74%) for PBS, DMEM and RPMI viability, respectively. At all three electric field levels (750, 1000, and 1250 V/cm), cancer cell destruction in PBS was the most successful. Further, the gap between PBS and RPMI was much larger (p < 0.01 at 750, 1000, and 1250 V/cm) than that between DMEM and RPMI (p > 0.05 at 1000 and 1250 V/cm). However, even DMEM substantially decreased the post-IRE viability of AsPC-1 cells (p < 0.01) for 750, 1000, and 1250 V/cm over control. Thus, the suspending medium has a dramatic impact on the efficacy of IRE when all other physical conditions are held constant, suggesting that the local cell microenvironment could impact the efficacy of IRE.
As many patients with pancreatic cancer are, or can become, diabetic, 36 a relationship between glucose concentration on IRE pancreatic cell destruction was also studied. Increasing glucose concentration from 80 to 380 mg/dL, led to a significant increase in the survival of AsPC-1 cells from 16.5 to 30.4% (p < 0.05) after treatment with same set of electrical parameters (Fig. 4c) , demonstrating that IRE is less effective in inducing cell death in high glucose conditions.
Adaptive Resistance
To assess the ability of pancreatic cancer to adapt to IRE, the viability post IRE of naı¨ve cells (untreated) was compared to that of cells that had already experienced IRE treatment 5 days before. Cells for all groups were derived from the same original flask, and were divided into different group receiving same culture condition and were tested viability after IRE. At all field strengths (1000, 1250, and 1500 V/cm) a statistically higher viability resulted in the previously treated cells (Fig. 4d) . For instance, at 1000 V/cm, the cellular viability is 8% higher in previously treated vs. untreated cells (p < 0.01). At higher electric field strengths (1250 and 1500 V/cm), the viabilities of FIGURE 3. The in vitro assessment IRE outcome on two types of pancreatic cancer cell lines, KPC and AsPC-1. IRE causes more cell death (lower viability) by increased electric field and the number of pulses in both cell lines. KPC (left) is more responsive than AsPC-1 (right) to IRE treatments. Both cell types were tested at 750 and 1000 V/cm at 10, 50 and 99 pulses. Due to the differential susceptibility of these cells to IRE, the KPC were tested as low as 500 V/cm and AsPC-1 as high as 1250 V/cm. All data points are the result of n ‡ 6 trials and are reported as the average 6 standard deviation.
previously treated cells were more than 2.8 times higher than their untreated naı¨ve counterparts (8.7 vs. 25.3% and 5.7 vs. 16.3%, both p < 0.01). Thus, cell derived from PDA can acquire some resistance to repeated exposure to the same IRE treatment. Interestingly, we did not observe a significant difference in overall cell sizes before and 5 days after IRE treatment (14.90 ± 0.57 vs. 15.03 ± 0.61 lm, p > 0.5).
In Vivo Assessment and Physical Enhancement
Based on the simulation of electric field during IRE (Fig. 5a) , the electric field reaches more than 1250 V/cm within 2 9 4 mm area (circled by grey dashed line) at the center the tumor when 600 V is applied between the two electrodes, which made up about 1/4 of the tumor volume (circled region: 2 9 4 9 3 mm 3 , tumor volume 100 mm 3 ). To provide an initial treatment estimate we assume that cell injury will respond the same way in vivo as in vitro. Thus, knowing that the AsPC-1 viability is 41% at 1250 V/cm we can predict that at least 60% of the cells are dead within the region circled by dashed line (1250 V/cm or 1/4 of tumor volume). Therefore, the simulation predicts that roughly 15% of the cells are dead given the baseline IRE parameters (51 pulses, 50 ls, and 10 Hz). The large portion of ''less-than-lethal'' regions within the tumor will allow us to test for physical enhancements.
This modeling approach was complemented by experimental in vivo assessment of sham, baseline IRE (600 V between probes, 51 pulses, 50 ls, and 10 Hz) and physical enhancements (pulse timing and low frequency IRE). The sham group showed the most rapid tumor growth curve over 40 days (Fig. 5b ). In contrast, the average volume of baseline IRE treated tumors was statistically consistently 8-25% below sham throughout the tumor growth curve at day 5, 10, and 20 (p < 0.05). In addition to the baseline IRE treatment, two other treatment groups, namely ''pulsetiming'' and ''low frequency'' were assessed by comparing tumor volumes to control group (sham) at same days after the treatment, as shown in Fig. 5b . Compared to sham, pulse-timing led to tumor volumes 32-45% less than that observed in the sham group between day 10 and the end of monitoring of day 40 (p < 0.01). The overall reduction in tumor growth by pulse timing is substantially better than the baseline IRE treatment. Additionally, the low-frequency treat- ment outperformed both the baseline and pulse-timing groups by a large margin: tumor volumes were 52-64% smaller than those in the sham group during the first 40 days of IRE treatment (p < 0.01).
DISCUSSION
In this study, we have demonstrated baseline and enhanced protocols for IRE destruction of pancreatic carcinoma cells both in vitro and in vivo. As demonstrated in Fig. 3 , IRE parameters (electric field, number of pulses, pulse duration and pulse interval) can be selected to achieve pancreatic cancer cell destruction consistent with other cancer models. 22 In general, higher electric field and pulse number for a given set of electrical parameters in IRE contribute to lower cell viability. Nevertheless, the response of cancer cells to electric pulse in vitro (e.g., in cell suspension) and in vivo can be different and further studies under more physiologically relevant experimental conditions are warranted. Furthermore, cell properties (size and shape) have a significant effect on the electroporation outcome.
1 Yet, the in vitro tests we present provide a simple and high-throughput platform for testing response of cancer cells to IRE under a variety of conditions.
A wide range of cells have been tested for viability after IRE both in vitro and in vivo, including normal cells and cancerous cells. 22, 49 In our in vitro studies, both pancreatic cancer cells (AsPC-1 and KPC) and normal cells (HDF) were shown to be susceptible to IRE destruction. The KPC cells were found to be somewhat more susceptible than the AsPC-1 cells to IRE with HDFs susceptibility lying between the two as shown in Fig. 3 and Appendix. This can also be appreciated more directly through a comparison of an LE 50 , or median electric field needed to achieve 50% cell viability (medium lethal dose) given at 50 pulses with 50 ls pulse duration and 10 Hz pulsing frequency for cells in their native cell culture medium as shown in Table 1 . Table 1 demonstrates that different cells have different susceptibility to IRE, with LE 50 ranging from 400 to 1300 V/cm. We also see that human cancer cell lines generally have higher LE 50 than those from mouse, which suggests that a higher electric field is required for translating IRE treatment from mouse cancer models to a human cancer (e.g., prostate cancer TRAMP-C2 vs. LNCaP and pancreatic cancer KPC vs. AsPC-1). For comparison, even from the same species (e.g., human), cells of different cancer have different response to IRE, which suggests the need for careful characterization of IRE response in the given cancer or tissue of interest. There is no clear correlation between IRE susceptibility and size of cells, by comparing different cell lines listed in Table 1 .
Physical Enhancements
Physical enhancements by arrangement of the electrical pulses in Fig. 2c is an attractive and readily translatable approach to improve IRE outcomes. We have shown that low frequency (1 Hz) IRE pulsing is advantageous over conventional 10-Hz pulsing and that pulse-timing (i.e., adding a 30 s delay between pulse trains) can also enhance outcomes as recently shown for prostate cancer. 21 Compared to IRE treatment with higher pulsing rate, pulsing at the rate of the heart (roughly 1 Hz for human) is desirable as high voltage can induce cardiac arrhythmias and defibrillation, which pose a significant safety concern over application of IRE, especially when applied close to heart. 29 However, the risk can be mitigated by synchronization of IRE pulse delivery with the cardiac cycle. 10, 28, 29 In addition to the physiological reasoning for using lower frequency, our data now also shows that IRE around 1 Hz can be more efficient in destroying cancerous cells although the precise mechanism is not completely understood. We were able to repeat these studies both in vitro and in vivo (Figs. 4a and 5) and demonstrate that the lower frequency pulsing is the most important effective, although pulse timing is also helpful.
Importantly, the concept that physical ''pulsing'' parameters can be optimized for achieving improved IRE treatment efficacy has been proposed previously. 22 Briefly, membrane defects typically last longer (up to seconds) than the exertion of the electric field (less than 1 ms). Therefore, it is hypothesized that temporally distributed pulses extend the effort of recovery, thus causing more irreversible damage than reversible pulses on the membrane. Note that the IRE parameters including waveform, amplitude and repetition rate will be ultimately constrained by electrical hardware and clinical concerns such as treatment time, muscle contraction and localized heating. Further work in this area would greatly benefit from a model of the cell or tissue that could predict IRE treatment outcomes (IRE dose) at any given electrical parameters would be very beneficial.
Chemical Enhancements
The chemical microenvironment in IRE treatment volume can enhance destruction as shown in low glucose and PBS media in vitro (Fig. 4) . It has been shown that a variety of chemical substances are able to enhance IRE treatment, including chemotherapeutic drugs or cytotoxic agents for electrochemotherapy 16, 41 and calcium.
14 Other studies have shown that modifying membrane properties by surfactants, impeding the resealing process are effective in enhancing the IRE destructive potential. Such chemicals include DMSO, 20 
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23,46 and SDS. 34, 35 Here, by comparing the IRE effect on cells suspending in PBS, DMEM and RPMI, we have shown that inorganic compounds and common essential molecules in media can also play a crucial role determining the treatment outcome. For instance, the absence of amino acids, vitamins and glucose in PBS compared to cell culture media (DMEM and RPMI) may ultimately contribute the dramatic enhancement of IRE. The addition of a few vitamins (e.g., biotin, para-aminobenzoic acid and vitamin B 12 ) in RPMI medium compared to DMEM may also contribute to cell resistance to IRE. Although the exact underlying mechanism is not yet understood, medium conductivity 43 or electroporation-induced cell sensitization 11 have been proposed. It has been shown that patients with diabetes are more likely to have a poor pancreatic cancer prognosis. 4 Additionally, a lower glucose level is likely to improve pancreatic cancer cell destruction by IRE treatment. Thus, we believe a reduction in blood glucose levels in pancreatic cancer patients during IRE treatment may improve pancreatic cancer outcomes, given the facts that patients are 5 times more likely to have impaired fasting glucose and 26 times more likely to be diabetic compared to general population. 36 Although the mechanism behind glucose deprivation and enhanced IRE treatment outcome is not fully understood, treatment strategies that target metabolic pathways during hyperthermia in cancer are well known. 44 For instance, most cancer cells depend predominantly on glycolysis for energy production, 15 therefore cellular stress due to IRE or heat is likely to be augmented at low glucose concentrations whereas the metabolic function of the cell is compromised. In the case of IRE, this stress is perhaps exacerbated by loss of intracellular enzymes needed for glycolysis. 27 A more rigorous study on the role of individual components in their enhancement or impediment of IRE treatment is needed. The method this study presented provides a platform to quickly identify molecules affecting IRE, which is in huge need for further investigation. The understanding of in vitro chemical enhancements and its underlying mechanism can be helpful in the development of in vivo adjuvant chemical approaches for enhancing IRE.
Adaptive Resistance
Our work highlights what appears to be a new phenomenon, that multiple treatments of the same cancer with IRE may lead to adaptive resistance and reduced efficacy of the IRE treatment. Specifically, surviving cells after initial IRE were shown to be substantially less susceptible to IRE destruction (Fig. 4d) . This seems similar to adaptive resistance observed in chemotherapy, 18 radiotherapy 5 and thermal therapy. 12, 25 The underlying mechanism may be related to physical changes to the membrane as the cells went through about two divisions between two treatments over 5 days. While this work is very preliminary, it does suggest that adaptive resistance of pancreatic cancer over IRE should be studied if repeated IRE treatments are likely, as secondary treatment may be less effective based on our results.
In Vivo Translation
While both chemical and physical methods of enhancement are likely to benefit IRE treatments in the future, we chose to initially demonstrate physical enhancement for in vivo translation. Importantly, adjuvant chemical approaches for enhancing IRE have already demonstrated great promise, as reviewed in. 22 However, controlled delivery or manipulation of drugs or chemicals in vivo to achieve the same conditions in vitro is challenging largely due to the physical barrier posed by stroma of pancreatic cancer. 40 Fortunately, physical enhancements based on pulse design can be directly implemented in vivo with just a few caveats. For instance, in the cuvette the electrical field strength is mostly uniform, whereas in the in vivo setting the field will vary spatially. However, the overall response from tumor growth delay can be used as a general metric of the impact of pulse design (i.e., physical enhancement) on treatment outcome, if everything else in model and protocol remain unchanged. Further, we can argue that IRE physical enhancement is unlikely to be interfered by resistive mechanism of cancer cells received prior biochemical treatment, and that the distribution of electric field within the tumor should remain relatively constant. Thus, physical enhancement by pulse timing, and low frequency pulsing were shown to yield statistically significant increases in pancreatic cancer destruction both in vitro and in vivo and suggest a possible path forward for clinical translation.
APPENDIX
Non-cancerous cells such as HDFs, can also be destroyed by IRE in a similar manner to cancer cells, as shown in Fig. 6 . Lower electric field (i.e., 500 V/cm) appear to do no damage to the cells with nearly 100% viability after IRE. The viabilities drop with both increased electric field (500-1250 V/cm) and number of pulses (10-99 pulses). Compared to pancreatic cancer cells (KPC and AsPC-1) studied, HDF appears to be slightly more resistant to IRE than KPC, with difference less 20% than on all conditions tested. However, HDF is more susceptible than AsPC-1, showing more than 20% decrease in violability after IRE with 1000-1250 V/cm and 50 pulses.
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